InvestorsHub Logo
Followers 35
Posts 182
Boards Moderated 0
Alias Born 05/03/2020

Re: eklab post# 124153

Sunday, 10/18/2020 3:22:40 AM

Sunday, October 18, 2020 3:22:40 AM

Post# of 232560
Those are the mortality rates of SOC and not that of Leronlimab!

39.5% or as much as 53.8% for critically ill patients for Standard of care; and

28% mortality rate for severe.

Leronlimab's ITT in both categories will be statistically significant over the controlled/ placebo subjects, IMO.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News